The treatment of chronic fatigue syndrome: science and speculation.
Wilson, A, Hickie, I, Lloyd, A et al. · The American journal of medicine · 1994 · DOI
Quick Summary
This review examined different treatments for ME/CFS and found that the condition is complex, affecting people in various ways. No single treatment has been proven to work well for most patients over the long term. The authors suggest that the best approach combines medical care, psychological support, and symptom management tailored to each person's needs.
Why It Matters
This review clarifies that ME/CFS requires individualized, multidisciplinary treatment approaches rather than one-size-fits-all solutions. It emphasizes the importance of studying patient subgroups and combination therapies, which remains relevant to current treatment strategy development and helps set realistic expectations for patients seeking care.
Observed Findings
ME/CFS is a heterogeneous disorder with diverse presentations including fatigue, neuropsychiatric symptoms, and somatic complaints
Multiple controlled treatment studies exist but show inconsistent or limited efficacy
Integrated treatment programs addressing both medical and psychological aspects remain poorly studied
Symptom management and good clinical care can prevent secondary complications in many patients
Different pathophysiologic mechanisms likely underlie CFS in different patient subgroups
Inferred Conclusions
No single treatment has demonstrated clear long-term benefit for the majority of CFS patients
Future research should examine treatment responses across defined CFS subtypes rather than treating the population as homogeneous
Combined medical and psychological approaches may be more effective than single interventions, but this requires formal testing
Individualized, integrated clinical care focusing on symptom management offers the most realistic near-term benefit
Remaining Questions
Which biomarkers best predict treatment response in different CFS subtypes?
What This Study Does Not Prove
This review does not identify which specific treatments are effective for particular patients, nor does it prove that psychological factors cause ME/CFS. It cannot establish superiority of any single intervention and reflects the state of evidence in 1994; more recent studies may have changed the evidence landscape.